Highlights

[DPHARMA] YoY Quarter Result on 2013-09-30 [#3]

Stock [DPHARMA]: DUOPHARMA BIOTECH BHD
Announcement Date 19-Nov-2013
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2013
Quarter 30-Sep-2013  [#3]
Profit Trend QoQ -     -36.51%    YoY -     5.34%
Quarter Report


View:


Show?  YoY % Horiz. %

Quarter Result
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Revenue 80,302 79,372 44,819 40,845 29,521 36,767 34,464 15.13%
  YoY % 1.17% 77.09% 9.73% 38.36% -19.71% 6.68% -
  Horiz. % 233.00% 230.30% 130.05% 118.51% 85.66% 106.68% 100.00%
PBT 7,516 11,621 11,287 9,054 8,391 9,726 10,221 -4.99%
  YoY % -35.32% 2.96% 24.66% 7.90% -13.73% -4.84% -
  Horiz. % 73.53% 113.70% 110.43% 88.58% 82.10% 95.16% 100.00%
Tax -1,290 -2,998 -2,605 -2,268 -1,949 -2,205 -2,602 -11.03%
  YoY % 56.97% -15.09% -14.86% -16.37% 11.61% 15.26% -
  Horiz. % 49.58% 115.22% 100.12% 87.16% 74.90% 84.74% 100.00%
NP 6,226 8,623 8,682 6,786 6,442 7,521 7,619 -3.31%
  YoY % -27.80% -0.68% 27.94% 5.34% -14.35% -1.29% -
  Horiz. % 81.72% 113.18% 113.95% 89.07% 84.55% 98.71% 100.00%
NP to SH 6,341 8,623 8,682 6,786 6,442 7,521 7,619 -3.01%
  YoY % -26.46% -0.68% 27.94% 5.34% -14.35% -1.29% -
  Horiz. % 83.23% 113.18% 113.95% 89.07% 84.55% 98.71% 100.00%
Tax Rate 17.16 % 25.80 % 23.08 % 25.05 % 23.23 % 22.67 % 25.46 % -6.36%
  YoY % -33.49% 11.79% -7.86% 7.83% 2.47% -10.96% -
  Horiz. % 67.40% 101.34% 90.65% 98.39% 91.24% 89.04% 100.00%
Total Cost 74,076 70,749 36,137 34,059 23,079 29,246 26,845 18.41%
  YoY % 4.70% 95.78% 6.10% 47.58% -21.09% 8.94% -
  Horiz. % 275.94% 263.55% 134.61% 126.87% 85.97% 108.94% 100.00%
Net Worth 451,913 268,509 187,531 179,017 167,991 162,353 148,494 20.36%
  YoY % 68.30% 43.18% 4.76% 6.56% 3.47% 9.33% -
  Horiz. % 304.33% 180.82% 126.29% 120.56% 113.13% 109.33% 100.00%
Dividend
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Div - - - - - - - -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Div Payout % - % - % - % - % - % - % - % -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Equity
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Net Worth 451,913 268,509 187,531 179,017 167,991 162,353 148,494 20.36%
  YoY % 68.30% 43.18% 4.76% 6.56% 3.47% 9.33% -
  Horiz. % 304.33% 180.82% 126.29% 120.56% 113.13% 109.33% 100.00%
NOSH 278,959 166,776 138,912 138,773 138,836 138,763 138,779 12.33%
  YoY % 67.27% 20.06% 0.10% -0.05% 0.05% -0.01% -
  Horiz. % 201.01% 120.17% 100.10% 100.00% 100.04% 99.99% 100.00%
Ratio Analysis
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
NP Margin 7.75 % 10.86 % 19.37 % 16.61 % 21.82 % 20.46 % 22.11 % -16.02%
  YoY % -28.64% -43.93% 16.62% -23.88% 6.65% -7.46% -
  Horiz. % 35.05% 49.12% 87.61% 75.12% 98.69% 92.54% 100.00%
ROE 1.40 % 3.21 % 4.63 % 3.79 % 3.83 % 4.63 % 5.13 % -19.45%
  YoY % -56.39% -30.67% 22.16% -1.04% -17.28% -9.75% -
  Horiz. % 27.29% 62.57% 90.25% 73.88% 74.66% 90.25% 100.00%
Per Share
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
RPS 28.79 47.59 32.26 29.43 21.26 26.50 24.83 2.49%
  YoY % -39.50% 47.52% 9.62% 38.43% -19.77% 6.73% -
  Horiz. % 115.95% 191.66% 129.92% 118.53% 85.62% 106.73% 100.00%
EPS 2.23 5.17 6.25 4.89 4.64 5.42 5.49 -13.93%
  YoY % -56.87% -17.28% 27.81% 5.39% -14.39% -1.28% -
  Horiz. % 40.62% 94.17% 113.84% 89.07% 84.52% 98.72% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 1.6200 1.6100 1.3500 1.2900 1.2100 1.1700 1.0700 7.15%
  YoY % 0.62% 19.26% 4.65% 6.61% 3.42% 9.35% -
  Horiz. % 151.40% 150.47% 126.17% 120.56% 113.08% 109.35% 100.00%
Adjusted Per Share Value based on latest NOSH - 706,330
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
RPS 11.37 11.24 6.35 5.78 4.18 5.21 4.88 15.12%
  YoY % 1.16% 77.01% 9.86% 38.28% -19.77% 6.76% -
  Horiz. % 232.99% 230.33% 130.12% 118.44% 85.66% 106.76% 100.00%
EPS 0.90 1.22 1.23 0.96 0.91 1.06 1.08 -2.99%
  YoY % -26.23% -0.81% 28.13% 5.49% -14.15% -1.85% -
  Horiz. % 83.33% 112.96% 113.89% 88.89% 84.26% 98.15% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.6398 0.3801 0.2655 0.2534 0.2378 0.2299 0.2102 20.36%
  YoY % 68.32% 43.16% 4.78% 6.56% 3.44% 9.37% -
  Horiz. % 304.38% 180.83% 126.31% 120.55% 113.13% 109.37% 100.00%
Price Multiplier on Financial Quarter End Date
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Date 30/09/16 30/09/15 30/09/14 30/09/13 28/09/12 30/09/11 30/09/10 -
Price 2.0600 2.7200 3.1700 2.5500 2.3600 2.1000 2.4400 -
P/RPS 7.16 5.72 9.83 8.66 11.10 7.93 9.83 -5.14%
  YoY % 25.17% -41.81% 13.51% -21.98% 39.97% -19.33% -
  Horiz. % 72.84% 58.19% 100.00% 88.10% 112.92% 80.67% 100.00%
P/EPS 90.63 52.61 50.72 52.15 50.86 38.75 44.44 12.60%
  YoY % 72.27% 3.73% -2.74% 2.54% 31.25% -12.80% -
  Horiz. % 203.94% 118.38% 114.13% 117.35% 114.45% 87.20% 100.00%
EY 1.10 1.90 1.97 1.92 1.97 2.58 2.25 -11.23%
  YoY % -42.11% -3.55% 2.60% -2.54% -23.64% 14.67% -
  Horiz. % 48.89% 84.44% 87.56% 85.33% 87.56% 114.67% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 1.27 1.69 2.35 1.98 1.95 1.79 2.28 -9.28%
  YoY % -24.85% -28.09% 18.69% 1.54% 8.94% -21.49% -
  Horiz. % 55.70% 74.12% 103.07% 86.84% 85.53% 78.51% 100.00%
Price Multiplier on Announcement Date
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Date 21/11/16 24/11/15 21/11/14 19/11/13 23/11/12 21/11/11 26/11/10 -
Price 2.1000 2.7000 3.0100 2.5600 2.2800 2.1000 2.3800 -
P/RPS 7.30 5.67 9.33 8.70 10.72 7.93 9.58 -4.43%
  YoY % 28.75% -39.23% 7.24% -18.84% 35.18% -17.22% -
  Horiz. % 76.20% 59.19% 97.39% 90.81% 111.90% 82.78% 100.00%
P/EPS 92.39 52.22 48.16 52.35 49.14 38.75 43.35 13.43%
  YoY % 76.92% 8.43% -8.00% 6.53% 26.81% -10.61% -
  Horiz. % 213.13% 120.46% 111.10% 120.76% 113.36% 89.39% 100.00%
EY 1.08 1.91 2.08 1.91 2.04 2.58 2.31 -11.89%
  YoY % -43.46% -8.17% 8.90% -6.37% -20.93% 11.69% -
  Horiz. % 46.75% 82.68% 90.04% 82.68% 88.31% 111.69% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 1.30 1.68 2.23 1.98 1.88 1.79 2.22 -8.53%
  YoY % -22.62% -24.66% 12.63% 5.32% 5.03% -19.37% -
  Horiz. % 58.56% 75.68% 100.45% 89.19% 84.68% 80.63% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Perform Technical & Fundamental Analysis on Stocks
MQ Affiliate
Earn rewards by referring your friends
 
 

572  344  555 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 FINTEC 0.035+0.005 
 MMAG 0.185-0.005 
 VSOLAR 0.02+0.005 
 EURO 1.10-0.11 
 MTOUCHE 0.090.00 
 SERBADK 0.625-0.005 
 HHHCORP 0.190.00 
 MRDIY 3.900.00 
 FOCUS 0.04+0.005 
 EDARAN 1.17+0.265 

FEATURED POSTS

1. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. What Professor Dennis Etler said about China - Koon Yew Yin Koon Yew Yin's Blog
2. Serba Dinamik rombak struktur Lembaga Pengarah, lantik IIlyas Pakeer sebagai pengerusi Oil and Gas Malaysia News
3. [MUST READ] Important message for all investors who are planning to invest in AT or existing AT shareholders Important message for all investors who are planning to invest in AT or existing AT shareholders
4. UNCOMMON ACTIVITIES SPOTTED ON RECENT CORPORATE EXERCISE OF THIS COMPANY!! Swim With Sharks
5. BREAKING: The Las Vegas Strip Is Back and May Be Better Than Ever [SEE INSIDE FOR TRIPLE DIGIT GAINS] A blog to publish and share information
6. Singapore sees first day rush for Sinovac vaccine; as 16 Covid-19 cases announced on Friday (June 18) Good Articles to Share
7. Media - Attractive valuations as recovery prospects brighten AmInvest Research Reports
8. ECO WORLD DEVELOPMENT - Proven Track Record PublicInvest Research
PARTNERS & BROKERS